Provided by Tiger Fintech (Singapore) Pte. Ltd.

Invivyd, Inc.

0.5939
+0.073814.19%
Volume:2.28M
Turnover:1.28M
Market Cap:115.81M
PE:-0.65
High:0.5978
Open:0.5334
Low:0.5170
Close:0.5201
52wk High:2.74
52wk Low:0.3546
Shares:195.00M
Float Shares:126.00M
Volume Ratio:1.14
T/O Rate:1.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9194
EPS(LYR):-1.4333
ROE:-120.08%
ROA:-53.25%
PB:2.71
PE(LYR):-0.41

Loading ...

Invivyd Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Yesterday

Invivyd Inc. Closes $57.5 Million Public Offering, Fully Exercises Underwriter's Option for Additional Shares

Reuters
·
Aug 23

Why Investors Shouldn't Be Surprised By Invivyd, Inc.'s (NASDAQ:IVVD) 31% Share Price Plunge

Simply Wall St.
·
Aug 22

Invivyd Prices $50 Million Offering of Stock, Warrants

MT Newswires Live
·
Aug 21

BRIEF-Invivyd Prices Public Offering At $0.52 Per Share

Reuters
·
Aug 21

Invivyd Announces Pricing of $50 Million Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
Aug 21

Invivyd Inc - Prices Public Offering at $0.52 per Share

THOMSON REUTERS
·
Aug 21

Invivyd announces common stock offering, no amount given

TIPRANKS
·
Aug 21

BRIEF-Invivyd Announces Proposed Public Offering Of Common Stock

Reuters
·
Aug 21

Invivyd Inc. Announces Public Offering of Common Stock to Advance Clinical Programs and Research Initiatives

Reuters
·
Aug 21

Invivyd : Grants Underwriters Option for 30 Days to Purchase up to 15% of Co's Common Stock Sold in Public Offering

THOMSON REUTERS
·
Aug 21

Invivyd Inc - Cantor Acting as Sole Book-Running Manager for Invivyd Offering

THOMSON REUTERS
·
Aug 21

Press Release: Invivyd Announces Proposed Public Offering of Common Stock

Dow Jones
·
Aug 21

Chief Human Resources Officer Julie Green Reports Disposal of Common Shares of Invivyd Inc

Reuters
·
Aug 20

Jill Andersen, Chief Legal Officer, Reports Disposal of Invivyd Inc. Common Shares

Reuters
·
Aug 20

Chief Scientific Officer Robert D. Allen III Reports Disposal of Invivyd Inc. Common Shares

Reuters
·
Aug 20

Invivyd Second Quarter 2025 Earnings: Misses Expectations

Simply Wall St.
·
Aug 19

Invivyd Is Maintained at Buy by D. Boral Capital

Dow Jones
·
Aug 19

Invivyd says PEMGARDA effective against XFG variant of SARS-CoV-2

TIPRANKS
·
Aug 19

BRIEF-Invivyd Announces Continued Neutralizing Activity Of Pemgarda And VYD2311 Against Currently Dominant Sars-Cov-2 Variant XFG

Reuters
·
Aug 19